19 results were returned
Before the entry into force of the GDPR on May 25th 2018, healthcare professionals and facilities and professionals in medico-social sectors empowered by law in France had to comply with the provisions stated in the ...
Biotech and medtech companies operate in an international environment where the composition of their governance bodies is a key criterion of credibility.
European Medicines Agency (EMA) had communicated to third parties (with some omissions), information contained in toxicological test reports and clinical trial reports obtained in a MA application file on the grounds ...
The French Health Data Hub was born officially with the publication on 30 November 2019 of a ministerial decision (arrêté).
The French so-called “anti-gift” provisions strictly frame the conditions under which companies in the health sector are allowed to provide advantages, in cash or in kind, to healthcare professionals ("HCPs”)
New CNIL standard for all companies doing product vigilance activities
French data protection law on health research applies to all sponsors, whatever their country of establishment, when they perform clinical trials in France.
The draft bill for the financing of the social security scheme for 2019, under discussion in the Parliament, contains, in its Article 43, amendment proposals to the French Public Health and Social Security Codes in ...
Transfer of value: new French legal framework effective as of July 1st but implementing texts are still missing.